Regulation of renal Microcirulation

肾脏微循环的调节

基本信息

  • 批准号:
    7595340
  • 负责人:
  • 金额:
    $ 36.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

In hypertension, renal vascular resistance increases, shifting the pressure natriuresis curve to the right. The afferent arteriole (Af-Art) accounts for most renal vascular resistance. It controls glomerular filtration rate and renal function. Af-Art resistance is regulated by factors similar to those that control other arterioles. In addition, the Af-Art is controlled by tubuloglomerular feedback (TGF). TGF operates via the macula densa, which senses increases in luminal NaCI and sends a signal to constrict the Af-Art. The kidney expresses heme oxygenases (HOs), which release carbon monoxide (CO), biliverdin, and ferrous iron. We have evidence that HO inhibition potentiates TGF, while CO and biliverdin reduce it. We hypothesize that HOs in the macula densa produce CO and biliverdin, both of which act synergistically and in an autocrine manner to inhibit TGF. CO acts by inhibiting the Na-K-2CI cotransporter (NKCC2) and by blocking ATP release. Biliverdin acts by decreasing superoxide (O2-), thereby increasing NO bioavailability. This hypothesis will be tested in 4 aims: Aim I. Hypothesis: HO-2 in the macula densa releases CO, which inhibits TGF in an autocrine manner. Aim II. Hypothesis: CO inhibits TGF by stimulating cGMP production. cGMP inhibits TGF in part by activating cGMP-dependent protein kinase and cGMP-stimulated phosphodiesterase 2, thereby reducing cAMP concentration. A decrease in cAMP results in decreased NKCC2-dependent Na entry. Aim III. Hypothesis: CO-induced cGMP production inhibits TGF, in part, by blocking depolarization-induced Ca entry and/or inhibiting maxi-anion channel activity and ATP release. Aim IV. Hypothesis: HO-2 in the macula densa releases biliverdin, which decreases O2-. The decrease in O2- increases NO bioavailability. Via these mechanisms biliverdin inhibits TGF and potentiates the effects of CO. We will study TGF in vitro and in vivo. In addition to pharmacological probes, mice with HO-2, -1, or nitric oxide synthase 1gene deletion will be used. This project relates to the central theme because we will study autocrine factors (CO and biliverdin) produced by the macula densa cells that participate in the regulation of renal microcirculation, and as a result play a key role in regulating renal function. The information from this project will be integrated with that from all other projects. It will use all of the cores. The hypothesis that CO regulates TGF is a new paradigm and will lead to a better understanding of the mechanisms that control renal microcirculation and function.
在高血压中,肾血管阻力增加,使压力尿钠排泄曲线向右移动。的 输入小动脉(Af-Art)占大多数肾血管阻力。它控制肾小球滤过率, 肾功能Af-Art抵抗力受与控制其他小动脉的因素类似的因素调节。在 此外,Af-Art受肾小管肾小球反馈(TGF)控制。TGF通过致密斑起作用, 其感知腔NaCl的增加并发送信号以收缩Af-Art。 血红素加氧酶(HO),其释放一氧化碳(CO)、胆绿素和亚铁。我们有 证据表明HO抑制增强TGF,而CO和胆绿素减少它。 致密斑产生CO和胆绿素,两者协同作用并以自分泌方式起作用, 抑制TGF。CO通过抑制Na-K-2Cl协同转运蛋白(NKCC 2)和阻断ATP释放发挥作用。 胆绿素通过减少超氧化物(O2-),从而增加NO的生物利用度。这一假设将是 在4个目标中测试:目标I。假设:致密斑中的HO-2释放CO,其抑制TGF-β 1表达。 自分泌方式Aim II.假设:CO通过刺激cGMP的产生抑制TGF。cGMP抑制TGF 部分通过激活cGMP依赖性蛋白激酶和cGMP刺激的磷酸二酯酶2,从而 降低cAMP浓度。cAMP减少导致NKCC 2依赖性Na内流减少。目的 三.假设:CO诱导的cGMP产生抑制TGF,部分是通过阻断去极化诱导的Ca 进入和/或抑制最大阴离子通道活性和ATP释放。目标四。假设:黄斑中的HO-2 densa释放胆绿素,降低O2-。O2-的减少增加了NO的生物利用度。经由这些 机制胆绿素抑制TGF和加强CO的影响。我们将在体外和体内研究TGF。 除了药理学探针外,HO-2、HO-1或一氧化氮合酶1基因缺失的小鼠将被 采用这个项目涉及的中心主题,因为我们将研究自分泌因子(CO和胆绿素) 由参与肾微循环调节的致密斑细胞产生, 在调节肾功能中起关键作用。该项目的信息将与 所有其他项目。它将使用所有的核心。CO调节TGF的假说是一种新的范式, 将导致更好地了解控制肾脏微循环和功能的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oscar A. Carretero其他文献

Ren-2 Gene Salt Hypertensive Mice Lacking − Antagonist in Deoxycorticosterone Acetate Effects of Angiotensin-converting Enzyme Inhibitor and Angiotensin Type 1 Receptor
Ren-2基因盐高血压小鼠缺乏-醋酸脱氧皮质酮拮抗剂对血管紧张素转换酶抑制剂和血管紧张素1型受体的影响
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hongmei Peng;Oscar A. Carretero;M. Alfie;Julie A. Masura;N. Rhaleb
  • 通讯作者:
    N. Rhaleb
Cross-talk between arterioles and tubules in the kidney
  • DOI:
    10.1007/s00467-008-0852-8
  • 发表时间:
    2009-01-01
  • 期刊:
  • 影响因子:
    2.600
  • 作者:
    YiLin Ren;Jeffrey L. Garvin;Ruisheng Liu;Oscar A. Carretero
  • 通讯作者:
    Oscar A. Carretero
Effects of propranolol on the development of renovascular hypertension in the rat
  • DOI:
    10.1016/s0002-8703(77)80347-5
  • 发表时间:
    1977-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Andreas P. Niarchos;Om P. Gulati;Oscar A. Carretero
  • 通讯作者:
    Oscar A. Carretero
Urinary kallikrein and plasma renin during the reversal of renovascular hypertension in rats.
大鼠肾血管性高血压逆转过程中的尿激肽释放酶和血浆肾素。
Kinins mediate the antiproliferative effect of ramipril in rat carotid artery.
激肽介导雷米普利在大鼠颈动脉中的抗增殖作用。

Oscar A. Carretero的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oscar A. Carretero', 18)}}的其他基金

Tubuloglomerular Feedback Regulation by Carbon Monoxide
一氧化碳的肾小球反馈调节
  • 批准号:
    8376983
  • 财政年份:
    2012
  • 资助金额:
    $ 36.87万
  • 项目类别:
Regulation of the Renal Microcirculation by the Connecting Tubule
连接小管对肾脏微循环的调节
  • 批准号:
    8034726
  • 财政年份:
    2008
  • 资助金额:
    $ 36.87万
  • 项目类别:
Regulation of the Renal Microcirculation by the Connecting Tubule
连接小管对肾脏微循环的调节
  • 批准号:
    7356857
  • 财政年份:
    2008
  • 资助金额:
    $ 36.87万
  • 项目类别:
Regulation of the Renal Microcirculation by the Connecting Tubule
连接小管对肾脏微循环的调节
  • 批准号:
    7766928
  • 财政年份:
    2008
  • 资助金额:
    $ 36.87万
  • 项目类别:
Regulation of the Renal Microcirculation by the Connecting Tubule
连接小管对肾脏微循环的调节
  • 批准号:
    7580940
  • 财政年份:
    2008
  • 资助金额:
    $ 36.87万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7249774
  • 财政年份:
    2007
  • 资助金额:
    $ 36.87万
  • 项目类别:
Ang II-Induced Hypertension: Role of Ac-SDKP in End Organ Damage
Ang II 诱发的高血压:Ac-SDKP 在终末器官损伤中的作用
  • 批准号:
    7249766
  • 财政年份:
    2007
  • 资助金额:
    $ 36.87万
  • 项目类别:
Regulation of Renal Microcirculation in Ang II-Induced Hypertension
血管紧张素II诱发高血压肾微循环的调节
  • 批准号:
    7249769
  • 财政年份:
    2007
  • 资助金额:
    $ 36.87万
  • 项目类别:
AUTOCRINE/PARACRINE REGULATION OF RENAL MICROCIRCULATION
肾微循环的自分泌/旁分泌调节
  • 批准号:
    6649479
  • 财政年份:
    2002
  • 资助金额:
    $ 36.87万
  • 项目类别:
Ac-SDKP in target organ damage in hypertension
Ac-SDKP 在高血压靶器官损伤中的作用
  • 批准号:
    6649484
  • 财政年份:
    2002
  • 资助金额:
    $ 36.87万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.87万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.87万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.87万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.87万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.87万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.87万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.87万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.87万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.87万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.87万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了